Avoiding Harm From Hyperbilirubinemia Screening—Reply

Abstract

The authors are currently serving as volunteer chair (Dr Kemper) and co-chair (Dr Newman) of an American Academy of Pediatrics committee revising guidelines for treatment of hyperbilirubinemia in infants born at at least 35 weeks' gestation. Dr Newman reported personal fees and nonfinancial support from the American Academy of Pediatrics and Letters 1208